1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Scleroderma, Limited: new trials by email Literature Review of Scleroderma, Limited trials Research Report on Scleroderma, Limited
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Oral Ifetroban, Oral Placebo - Scleroderma, Diffuse, Scleroderma, Systemic | Phase 2 | Active not recruiting | Cumberland Pharmaceuticals | 34 | 2017-01-01 | 2026-09-02 |
Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Pathologic Processes (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1) · Skin Diseases (1)
Immune System Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Skin and Connective Tissue Diseases (1)
ifetroban (1)
Cumberland Pharmaceuticals (1)
India (1) · United States (1)